About MiMedx Group
MiMedx Group is a company based in Marietta (United States) founded in 1985. The company has 837 employees as of December 31, 2024. MiMedx Group has completed 2 acquisitions, including SpineMedica and Stability Biologics. MiMedx Group offers products and services including EPIFIX, EPICORD, AMNIOFIX, AMNIOCORD, and AXIOFILL. MiMedx Group operates in a competitive market with competitors including Theradaptive, Ossio, RevBio, Aziyo Biologics and EpiBone, among others.
- Headquarter Marietta, United States
- Employees 837 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mimedx Group, Inc
-
Annual Revenue
$348.88 M (USD)8.52as on Dec 31, 2024
-
Net Profit
$42.42 M (USD)-27.15as on Dec 31, 2024
-
EBITDA
$62.35 M (USD)53.8as on Dec 31, 2024
-
Latest Funding Round
$100 M (USD), Post-IPO
Jul 02, 2020
-
Investors
Hayfin
& 2 more
-
Employee Count
837
as on Dec 31, 2024
-
Investments & Acquisitions
SpineMedica
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MiMedx Group
MiMedx Group is a publicly listed company on the NASDAQ with ticker symbol MDXG in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of MiMedx Group
MiMedx Group offers a comprehensive portfolio of products and services, including EPIFIX, EPICORD, AMNIOFIX, AMNIOCORD, and AXIOFILL.
Placental tissue product for promoting wound healing in patients.
Biologic for wound care to support tissue regeneration effectively.
Product aiding surgical healing with placental materials.
Biologic for surgical applications to enhance recovery processes.
Material for surgical use in tissue repair and support.
People of MiMedx Group
Unlock access to complete
Leadership Team
130 people
Sales and Marketing
37 people
Senior Team
12 people
Product Management Team
10 people
Software Development Team
10 people
Finance and Accounting
8 people
Operations Team
7 people
Legal and Compliance
7 people
Unlock access to complete
Funding Insights of MiMedx Group
Investors in MiMedx Group
MiMedx Group has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Hayfin, EW Healthcare Partners and Blue Torch Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Locked | Locked | Locked | |
|
Private debt investments are directed across multiple sectors.
|
Locked | Locked | Locked | |
|
Blue Torch Capital is engaged in private credit investment management.
|
Locked | Locked | Locked |
Investor details for MiMedx Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MiMedx Group
MiMedx Group has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include SpineMedica and Stability Biologics.
Investment portfolio details for MiMedx Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bone and skin tissues are developed for medical grafting applications.
|
Locked | Locked | 2010 | Locked | |
|
Spine alignment devices and artificial spinal implants
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for MiMedx Group
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - MiMedx Group
Detailed financials for MiMedx Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mimedx Group Comparisons
Peer comparison for MiMedx Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MiMedx Group
MiMedx Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theradaptive, Ossio, RevBio, Aziyo Biologics and EpiBone, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Synthetic adhesives for bone and dental repair are developed.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
Detailed competitors of MiMedx Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mimedx Group
Complete news archive for MiMedx Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MiMedx Group
MiMedx Group was founded in 1985 and raised its 1st funding round 24 years after it was founded.
MiMedx Group is headquartered in Marietta, United States. It is registered at Marietta, Georgia, United States.
As of Dec 31, 2024, the latest employee count at MiMedx Group is 837.
Annual revenue of MiMedx Group is $348.88M as on Dec 31, 2024.
MiMedx Group was founded in 1985 and is headquartered in Marietta, United States. Operations center on regenerative medicine within the biomaterials sector, where products are processed from human amniotic membranes and collagen fibers for applications in wound care, surgery, sports medicine, and orthopedics. Key technologies encompass AmnioFix and EpiFix from donated placentas, CollaFix with cross-linked polymers, and OrthoFlo as an amniotic fluid allograft for tissue repair.
MiMedx Group's top competitors include EpiBone, Theradaptive and Ossio.
MiMedx Group offers EPIFIX, EPICORD, AMNIOFIX, AMNIOCORD, and AXIOFILL.
Yes, MiMedx Group is publicly traded on NASDAQ under the ticker symbol MDXG.
MiMedx Group has made 2 acquisitions, including SpineMedica, and Stability Biologics.
MiMedx Group has 3 investors. Key investors include Hayfin, EW Healthcare Partners, and Blue Torch Capital.
The ticker symbol of MiMedx Group is MDXG on NASDAQ.